Abstract
Pulmonary hypertension (PH) is a major complication of several haematological disorders. Chronic myeloproliferative diseases (CMPDs) associated with pulmonary hypertension have been included in group five of the clinical classification for pulmonary hypertension, corresponding to pulmonary hypertension for which the aetiology is unclear and/or multifactorial. The aim of this review is to discuss the epidemiology, pathogenic mechanism and treatment approaches of the more common forms of pulmonary hypertension in the context of CMPD’s: chronic thromboembolic pulmonary hypertension, precapillary pulmonary hypertension and drug-induced PH.
| Original language | English |
|---|---|
| Pages (from-to) | 400-410 |
| Number of pages | 11 |
| Journal | European Respiratory Review |
| Volume | 24 |
| Issue number | 137 |
| DOIs | |
| Publication status | Published - Sep 1 2015 |
Fingerprint
ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine
Cite this
Pulmonary hypertension in patients with chronic myeloproliferative disorders. / Adir, Yochai; Elia, Davide; Harari, Sergio.
In: European Respiratory Review, Vol. 24, No. 137, 01.09.2015, p. 400-410.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Pulmonary hypertension in patients with chronic myeloproliferative disorders
AU - Adir, Yochai
AU - Elia, Davide
AU - Harari, Sergio
PY - 2015/9/1
Y1 - 2015/9/1
N2 - Pulmonary hypertension (PH) is a major complication of several haematological disorders. Chronic myeloproliferative diseases (CMPDs) associated with pulmonary hypertension have been included in group five of the clinical classification for pulmonary hypertension, corresponding to pulmonary hypertension for which the aetiology is unclear and/or multifactorial. The aim of this review is to discuss the epidemiology, pathogenic mechanism and treatment approaches of the more common forms of pulmonary hypertension in the context of CMPD’s: chronic thromboembolic pulmonary hypertension, precapillary pulmonary hypertension and drug-induced PH.
AB - Pulmonary hypertension (PH) is a major complication of several haematological disorders. Chronic myeloproliferative diseases (CMPDs) associated with pulmonary hypertension have been included in group five of the clinical classification for pulmonary hypertension, corresponding to pulmonary hypertension for which the aetiology is unclear and/or multifactorial. The aim of this review is to discuss the epidemiology, pathogenic mechanism and treatment approaches of the more common forms of pulmonary hypertension in the context of CMPD’s: chronic thromboembolic pulmonary hypertension, precapillary pulmonary hypertension and drug-induced PH.
UR - http://www.scopus.com/inward/record.url?scp=84940652737&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84940652737&partnerID=8YFLogxK
U2 - 10.1183/16000617.0041-2015
DO - 10.1183/16000617.0041-2015
M3 - Article
VL - 24
SP - 400
EP - 410
JO - European Respiratory Review
JF - European Respiratory Review
SN - 0905-9180
IS - 137
ER -